Compounded semaglutide cost ran $49 to $79 a month at the two cash-pay programs we checked on November 4, 2026, or about $588 to $1,027 for a full year. What moves it: prepaying, membership fees, and whether a "month" means four weeks. Brand-name Wegovy costs $349 a month self-pay after an intro offer.
The cheapest yearly total and the cheapest way to try it aren't the same plan. The tables below show both, plus the refund rules that decide what you're really out if you stop early.
The RX Index is the independent GLP-1 decision resource that scores telehealth providers and treatment paths on clinical legitimacy, care quality, transparency, access, and cost, so readers can choose the path that fits their situation.
RX Index Decision Verdict: Compounded semaglutide can cost under $1,000 a year, but the lowest totals come with a catch: a yearly membership or a year paid up front that you can't get back.
- Best for: Cash payers who are comfortable with a medication that isn't FDA-approved and want a flat price at every dose.
- Not ideal for: Anyone who wants an FDA-approved drug, needs insurance to pay, or isn't sure they'll stay on treatment for more than a month or two.
- The factor that matters most: How long you'll really stay. Commitment cuts the price, and refunds mostly don't exist.
Compounded semaglutide cost at a glance
As of November 4, 2026, Collective charged $59 a month plus a $199 yearly membership, and Embody charged $49 to $79 a month depending on plan length, with no membership. Both say the price is the same at every dose. Both are compounded, not FDA-approved.
| Program and plan | Posted price | Membership | What the price covers | 12-month total (our math) |
|---|---|---|---|---|
| Collective, month to month | $59 a month | $199 a year, after a 21-day free trial | Medication; the membership covers doctor care and shipping | $907 |
| Embody, monthly plan | $79 a month | None | All doses, shipping and provider visits | $948 to $1,027 |
| Embody, 3-month plan | $76 a month ($228 per term) | None | Same | $912 for four terms |
| Embody, 6-month plan | $73 a month ($438 per term) | None | Same | $876 for two terms |
| Embody, 12-month plan | $49 a month ($588 per term) | None | Same | $588 |
Prices from Collective's weight-loss page and Embody's terms and conditions, checked November 4, 2026. Embody's terms list these plans as monthly, 3-, 6- and 12-month, while its FAQ describes 4-, 12-, 24- and 52-week plans. If "monthly" means every four weeks, you'd pay 13 times a year, which is why its monthly row shows a range.
Not sure compounded is even your path? The right GLP-1 option isn't the same for everyone. It depends on your state, your insurance, whether you want FDA-approved or compounded, shot or pill, and your budget. The RX Index's Find My GLP-1 Path tool sorts that out in about 2 minutes before you pay anyone.
What a year of compounded semaglutide costs
A year of compounded semaglutide cost $588 to $1,027 at the plans we checked, as of November 4, 2026. The lowest total needs a full year paid as one purchase. The lowest no-commitment total was Collective's $907, which includes its $199 membership.
Here's the whole receipt over time, the way our methodology measures cost: medication plus any required membership, at month one, month four and the end of year one.
| Plan | Paid by end of month 1 | Paid by end of month 4 | Paid in year one | Cost per weekly dose |
|---|---|---|---|---|
| Collective, kept past day 21 | $258 | $435 | $907 | $17.44 |
| Collective, cancelled before day 21 | $59 | — | $59 | — |
| Embody monthly | $79 | $316 | $948 (12 charges) or $1,027 (13 charges) | $19.75 |
| Embody 12-month | $588 | $588 | $588 | $11.31 |
Our math from the posted prices. Cost per weekly dose divides each plan's price by the weeks it covers. For Collective we assumed 12 monthly orders; if each order turned out to be a 4-week supply, a year would be 13 orders, or $966. For Embody's 12-month plan we assumed the full $588 is charged at checkout, since its refund policy calls bundles a single purchase; confirm that before you pay.
Two plain takeaways:
- If you're sure you'll stay a year, Embody's 12-month plan was the lowest total we found, $319 less than a year at Collective. But you pay for the year as one purchase, and Embody's refund policy says it's "non-refundable in whole and in part."
- If you want to try it first, Collective's trial is the cheapest way in. Cancel before day 21 and you've paid $59 for your first order. Wait past day 21 and the $199 membership is charged, which Collective's terms say isn't refundable.
Say you're 45, paying cash, and you've never taken a GLP-1. You don't know yet how you'll handle the nausea that's common early on. Starting with a no-prepay plan costs a little more per month, but it caps your risk at one order if it isn't for you.
If a low monthly price with no multi-month commitment is what you're after, you can see whether Collective's plan fits you. Its doctors decide whether you qualify.
Try Collective's $59 semaglutide plan (sponsored affiliate link, opens in a new tab)
For the same math on the tirzepatide side, see our compounded tirzepatide cost guide. For every detail of one program, see our Collective GLP-1 cost breakdown.
Why the price you see isn't always the price you pay
A compounded semaglutide price tag can leave out a membership, a prepayment, the length of a "month," and small fees. Those four things can move a year's total by hundreds of dollars. Check each one before you compare two offers.
- Membership fees. Collective's $59 doesn't include its $199 yearly membership. Embody says it has "no membership or hidden fees." A $59 price plus $199 a year averages about $75.58 a month over 12 orders.
- Prepaying. Embody's $49 rate is its 12-month plan, sold as one purchase for the whole term. Its month-to-month rate is $79.
- Four weeks vs a calendar month. Thirteen four-week charges fit in a year, not 12. On a $79 plan, that's the difference between $948 and $1,027.
- Dose pricing. Some programs charge more as your dose goes up. Collective says "same price, any dose," and Embody's FAQ says its price doesn't increase if your dose changes within the same medication.
- Small print fees. Collective's terms allow a "nominal, uniform technology transaction fee" per electronic prescription and don't post the amount. Embody's terms say "the final charge may vary based on the prescribed medication and the selected pharmacy." Neither shows sales tax on its price page.
An unknown fee isn't a zero fee. Our GLP-1 cost calculator can help you run a quote you get anywhere else.
Refund and cancellation rules that change your real cost
Refunds mostly don't exist for compounded semaglutide plans. At both programs we checked, the main exception is if the prescriber decides you aren't a candidate. That makes the length of your plan a money decision, not just a price choice.
| Situation | Collective | Embody |
|---|---|---|
| Prescriber says it isn't right for you | FAQ: "you get a full refund" | Refund of the unused part of your term, minus services already provided |
| You cancel early | Cancel before day 21 and you're never charged the membership | Cancel at least 72 hours before your next billing date, or that charge goes through and isn't refundable |
| You cancel mid-plan | Terms: membership fees non-refundable, no partial-period refunds | Bundles are "non-refundable in whole and in part" |
| Medication already sent | Terms: products can't be returned and are non-refundable unless Collective decides otherwise | Medication that's been prescribed, compounded or shipped isn't eligible for return or refund |
Sources: Collective's Terms of Use (version 2026-08-12) and FAQ; Embody's terms (last updated April 24, 2026) and refund policy (last updated August 25, 2026).
Here's how that plays out. Say you buy Embody's 12-month plan for $588 and stop after three months. You've still paid $588. On Embody's monthly plan, three months would have cost $237. The prepaid plan only wins if you're confident you'll stay.
If you've done that gut check and a year at one flat price is the plan, Embody's 12-month option was the lowest yearly total we found today.
Compare Embody's 12-month price (sponsored affiliate link, opens in a new tab)
Is compounded semaglutide cheaper than Wegovy?
Yes, by a wide margin on price. As of November 4, 2026, a year of compounded semaglutide cost $588 to $1,027 at the plans we checked, while a year of brand-name Wegovy pens cost about $4,237 to $4,537 for the medication alone. But they aren't the same product: Wegovy is FDA-approved, and compounded semaglutide is not.
| Option | FDA-approved? | Posted self-pay price | About a year (our math) |
|---|---|---|---|
| Compounded semaglutide, Embody 12-month | No | $49 a month | $588 |
| Compounded semaglutide, Collective | No | $59 a month + $199 a year | $907 |
| Wegovy pen, Novo Nordisk self-pay | Yes | $349 a month (0.25 to 2.4 mg); new patients pay $199 for their first 2 months of 0.25 or 0.5 mg, through December 31, 2026 | $4,237 with the intro, $4,537 without |
| Wegovy HD 7.2 mg pen | Yes | $399 a month | $5,187 |
| Wegovy pill | Yes | $149 (1.5 mg), $199 (4 mg), $299 (9 mg and 25 mg) a month | Depends on dose |
Brand prices are from Novo Nordisk's Wegovy savings page, checked November 4, 2026. Novo defines a pen month as one box of 4 pens, so our yearly figures use 13 boxes for 52 weeks. Brand prices don't include a prescriber visit. On Medicare, Novo says eligible people can get Wegovy pen or pill for $50 a month through the Medicare GLP-1 Bridge from July 1, 2026 to December 31, 2027, with prior authorization.
You may also see Ozempic mentioned in the same breath. Ozempic is semaglutide too, but it's FDA-approved for type 2 diabetes, not for weight loss.
What the price gap buys: Wegovy went through FDA review for safety, effectiveness and quality. Compounded versions don't. Our guide to compounded GLP-1s vs name brands explains the trade-off. If you want the FDA-approved route, see the cheapest ways to get Wegovy without insurance, the Wegovy pill's cost without insurance, or how Ro handles Wegovy if you want help with coverage.
Is compounded semaglutide still legal in 2026?
Yes, in narrower form. The FDA declared the semaglutide injection shortage resolved on February 21, 2025. That ended the shortage-era leeway for making copies of the approved drug, which ran out in April 2025 for pharmacies and May 2025 for outsourcing facilities. As of November 4, 2026, state-licensed pharmacies can still compound semaglutide for an individual patient's prescription under strict limits.
Here's what the FDA's own pages say, as of today:
- Not on the shortage list. In its April 1, 2026 update, the FDA said semaglutide doesn't appear on its drug shortage list or on the 503B bulks list. The FDA's shortage database today lists no semaglutide injection shortage.
- Pharmacies (503A) need a prescription for one patient and can't regularly make "essentially copies" of an approved drug unless the prescriber documents a significant difference for that patient. The FDA said it doesn't intend to act if a pharmacy fills four or fewer such prescriptions a month.
- Outsourcing facilities (503B) can't use bulk semaglutide unless it's on the 503B bulks list or in shortage. On May 1, 2026, the FDA proposed not to add semaglutide to that list. Comments closed July 30, 2026, and we found no final decision as of November 4, 2026.
What that means for your wallet: a program's ability to keep filling your prescription depends on rules that can change. Our explainers on whether compounded semaglutide is being discontinued and the 503B bulks list go deeper, and compounded GLP-1 laws by state covers state rules.
How to spot a compounded semaglutide price that's too good to be true
The FDA lists deep discounts and prices that "seem too good to be true" as a red flag. So is any claim that a compounded drug is the same as an FDA-approved one. A real offer comes with a prescriber's review, a prescription in your name and a licensed pharmacy.
The FDA's page on unapproved GLP-1 drugs (current as of October 1, 2026) also warns about:
- Salt forms. Semaglutide sodium and semaglutide acetate are different ingredients from the one in approved drugs, and the FDA says it isn't aware of any lawful basis for compounding with them. Ask which form you'd get.
- Fake labels. The FDA has found fraudulent compounded semaglutide with labels naming pharmacies that don't exist or didn't make the product.
- "Research" vials. Products sold "for research purposes" or "not for human consumption" aren't a safe way to save money.
- Dosing mistakes. The FDA has received adverse event reports, some needing a hospital stay, that may be tied to dosing errors with compounded semaglutide, including people measuring the wrong dose.
As of May 31, 2026, the FDA said it had received 990 adverse event reports tied to compounded semaglutide, and that the real number is likely higher because pharmacies that aren't outsourcing facilities aren't required to report them.
Ask any program which pharmacy fills your prescription. Embody names four partner pharmacies on its site. Collective says its prescriptions are filled by state-licensed US pharmacies with third-party-tested batches, but it doesn't name the pharmacy publicly.
Can you use insurance or an HSA for compounded semaglutide?
Insurance almost never pays for compounded semaglutide. Both programs we checked are cash pay. HSA and FSA money may work, but your plan, not the program, decides.
- Insurance: Collective says it doesn't bill insurance. Embody's terms say its affiliated medical providers aren't contracted with any health plan, including Medicare and Medicaid.
- HSA/FSA: Collective says your medication and membership "may qualify" for reimbursement and offers itemized receipts on its HSA/FSA page. Embody's home page says "HSA/FSA Approved." Either way, your plan administrator makes the call.
Paying with pre-tax dollars lowers your real cost. Our guide on whether compounded semaglutide is HSA eligible walks through the rules.
Which compounded semaglutide plan fits you
The right plan depends on how sure you are and how long you'll stay. Use this to find your row, then check the one thing in the last column before you pay.
| Your situation | Plan that usually costs least | Check first |
|---|---|---|
| Brand new and unsure | Collective, cancelling before day 21 if it's not for you | Set a reminder for day 18 or 19 |
| Plan to stay several months, no prepaying | Collective month to month ($907 a year) | That you live in one of its 44 states |
| Sure you'll stay a full year | Embody 12-month ($588) | No refund for unused months |
| Want no membership at all | Embody monthly ($79) | 12 or 13 charges a year |
| Want FDA-approved medication | Wegovy pen or pill self-pay, or your insurance | Coverage and prior authorization |
| Have Medicare | Medicare GLP-1 Bridge for Wegovy | Prior authorization from your doctor |
Collective is available in 44 states. Its FAQ lists the six where it isn't yet: Alabama, California, Louisiana, Massachusetts, Mississippi and Washington. Embody's terms say it serves "certain states" and to contact its support team for the list.
If you're in one of Collective's states and want to start without prepaying, the next step is a short online health review. Collective's FAQ says you get a full refund if its doctor doesn't approve you.
See if Collective serves your state (sponsored affiliate link, opens in a new tab)
If no membership fee matters more to you than the trial, Embody's month-to-month plan is $79 with doses, shipping and provider visits included.
See Embody's semaglutide plans (sponsored affiliate link, opens in a new tab)
Safety first: do not use semaglutide if you or a family member has had medullary thyroid cancer (MTC), or if you have MEN 2. Tell the prescriber if you're pregnant, planning a pregnancy or breastfeeding, or if you've ever had pancreatitis. This page is about cost and isn't medical advice; a licensed clinician decides whether any GLP-1 is right for you.
Not sure compounded is right for you, or want to use insurance or an FDA-approved drug instead? That's a fair call, and there's a path for it.
What we actually verified
- Opened Collective's weight-loss page and FAQ, HSA/FSA page and Terms of Use (version 2026-08-12) for its semaglutide price, membership, trial, refunds, insurance and states.
- Opened Embody's home page and FAQ, terms and conditions (last updated April 24, 2026) and refund policy (last updated August 25, 2026) for its semaglutide plan prices, what's included, cancellation and refunds.
- Read Novo Nordisk's Wegovy savings page for brand self-pay and Medicare Bridge prices.
- Read the FDA's compounding statement (current as of April 1, 2026), its page on concerns with unapproved GLP-1 drugs (current as of October 1, 2026), the FDA drug shortage database, and the Federal Register notices on the 503B bulks list.
- Did all monthly, yearly and per-week math ourselves from those posted prices.
All checks were done on November 4, 2026. What we couldn't confirm: whether Collective's orders are calendar-month or 4-week supplies, the amount of Collective's technology fee, whether Embody charges the 12-month plan all at once at checkout, Embody's state list, and sales tax at either program. We didn't sign up or place an order. Prices change, so check the checkout page before you pay. The RX Index may earn a commission if you sign up through links on this page; it doesn't change our math.
Frequently asked questions
How much is compounded semaglutide per month?
At the two programs we checked on November 4, 2026, it was $49 to $79 a month. Embody charged $79 month to month or $49 a month on a 12-month plan, with no membership. Collective charged $59 a month plus a $199 yearly membership, which averages about $75.58 a month over a year.
How much does compounded semaglutide cost per year?
About $588 to $1,027 at the plans we checked. Embody's 12-month plan was $588, Collective came to $907 with its membership, and Embody's monthly plan came to $948 or $1,027 depending on whether you're billed 12 or 13 times. Those are our totals from posted prices.
Why is compounded semaglutide so much cheaper than Wegovy?
Compounded semaglutide is made by compounding pharmacies for individual prescriptions and doesn't go through FDA approval. That's also the main drawback: the FDA hasn't reviewed compounded versions for safety, effectiveness or quality. Wegovy pens cost $349 a month self-pay after Novo's intro offer.
Does compounded semaglutide cost more at higher doses?
Not at the two programs we checked. Collective says "same price, any dose," and Embody says its price doesn't go up if your dose changes. Other programs do charge more as the dose climbs, so ask before you sign up.
Is there a membership fee for compounded semaglutide?
It depends on the program. Collective requires a $199 yearly membership after a 21-day free trial, and the medication is billed separately. Embody says it charges no membership fee because doses, shipping and provider visits are in the plan price.
Can I get a refund if I stop compounded semaglutide?
Usually not. Collective's terms say membership fees aren't refundable after they're charged, and Embody's policy says its bundles are non-refundable in whole and in part. Both give refunds mainly when the prescriber decides you aren't a candidate.
Is compounded semaglutide still available in 2026?
Yes, from state-licensed pharmacies filling individual prescriptions, under the FDA's limits on copies of approved drugs. The FDA resolved the semaglutide shortage in February 2025 and proposed in May 2026 to keep semaglutide off the 503B bulks list. As of November 4, 2026, we found no final decision.
Sources
- Collective: weight-loss page and FAQ, HSA/FSA reimbursement, Terms of Use (version 2026-08-12) (checked November 4, 2026)
- Embody: home page and FAQ, terms and conditions (last updated April 24, 2026), refund policy (last updated August 25, 2026) (checked November 4, 2026)
- Novo Nordisk: Wegovy coverage and savings (checked November 4, 2026)
- FDA: policies for compounders as GLP-1 supply stabilizes (current as of April 1, 2026), concerns with unapproved GLP-1 drugs (current as of October 1, 2026), drug shortage data for semaglutide (checked November 4, 2026)
- Federal Register: 503B bulks list proposal (May 1, 2026) and comment period extension (June 26, 2026)
Still not sure which GLP-1 path fits you? Take The RX Index's free Find My GLP-1 Path quiz — about 2 minutes, no signup.